{"version":"1.0","type":"link","title":"Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315).","author_name":"Althoff FC 외","author_url":"https://prs-insight.online/author/Althoff%20FC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95879","thumbnail_width":1200,"thumbnail_height":630}